ALPK2 and ovarian cancer: In mouse xenograft models, the knockdown of ALPK2 inhibits the development and progression of ovarian cancer [43] and renal cancer cells [44], thus supporting its relevance not only in cancer initiation and development but also in the pathogenesis of liver disease.